EDGAR Filing Documents for 0001615774-17-002027

Form 8-K - Current report:

SEC Accession No. 0001615774-17-002027

Filing Date

2017-05-02

Accepted

2017-05-02 16:35:14

Documents

Period of Report

2017-04-26

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	s106031_8k.htm	8-K	18014
2	EXHIBIT 4.1	s106031_ex4-1.htm	EX-4.1	76576
3	EXHIBIT 4.2	s106031_ex4-2.htm	EX-4.2	110944
4	EXHIBIT 4.3	s106031_ex4-3.htm	EX-4.3	41741
	Complete submission text file	0001615774-17-002027.txt		248692

Mailing Address 354 MERRIMACK STREET #4 LAWRENCE MA 01843

Business Address 354 MERRIMACK STREET #4 LAWRENCE MA 01843 (603) 935-9799

Boston Therapeutics, Inc. (Filer) CIK: 0001473579 (see all company filings)